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of color Doppler automated cardiac output method (ACOM). Methods.’ LV
outflow waveforms (maximum velocities = 0.3-1.1 tisec) were generated
at cardiac output (CO) = 2-6 Umin, corresponding to SVS ranging from
13-100 ml/min and HRs of 80-150/min. A Toshiba PowerVision (3.7 MHz
transducer) was used to measure SV using two wall filters (4 kHz and 9 kHz)
and optimizing gain adjustment. Transmit power, PRF, frame rate, carrier
frequency and depth were held constant.
Results: SV by ACOM correlated well with SV by electromagnetic flow
meter (EMF) using either wall filter (4 kHz, r = 0.997 and 9 kHz, r = 0.995,
p < 0.001), although ACOM underestimated SV by EMF an additional 8%
(mean) at 9 kHz vs. 4 kHz. The % underestimation by ACOM [% difference
(% D) = (ACOM -EMF) x 100/EfWbecame larger at SV <30 mhat,
maximum = 30% at 4 kHz vs. 50Y. at 9 kHz (Fig. 1; 9 kHz). The combination
of techycardia and low SV results in even greater underestimation of CO (=
SV x HR) (Fig. 2; 9 kHz).
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Conclusions: In low output states, underestimation of SV and CO by
ACOM maybe large. These considerations maybe important in clinical CO
measurement.
m1049172 Contrast Intravascular Ultrasound ImagingImproves Detection of In-stent Neointima After
Palmsz-Schatz Coronary Stent Implantation
M. Terashima, J. Masuda, M. Hayakawa, K. Awano, T. Mori, R. Emoto,
K. Haftori, T. Inatome, H. Fukuzaki. Mild Cify Hospita/, Miki, Hyogo, Japan
Late Iuminal loss is known to occur within corona~ stents, resulting from in-
stent neointimal thickening. Intravascular ultrasound (IVUS) has been used
foranalysisof in-stent neointima. However,some difficulties are encountered
in detecting neointima with this method. To solve this problem, we propose
a new technique: injection of 25% Albunex into the coronary artery during
IVUS imaging (Contrast IVUS). The usefulness of this method in detecting
in-stent neointima was evaluated, compared with mnventional IVUS. Both
conventional and contrast IVUS (Hewlett Packard Sonos system and Boston
Scientific 3.5F, X3 MHz catheter) were performed in 24 cases at 6.5 + 1.5
montha after PaImaz-Schatz stent implantation. At the stenotic site within a
stent, neointima wasobsewed with various combinations of imaging controls
(acoustic power: 55and 99%, dynamic range: 46,51 and 54dB, post process:
B, D and F).
Results: Using conventional IVUS, we obtained complete delineation of
in-stent neointima in only 6 oaees, and could not identify any neointima
in 6 cases despite altering combinations of imaging controls variously. In
12 oases, delineation of neointima was incomplete. Using contrast IVUS,
the boundafy between neointima and enhanced lumen area was clearly
distinguished, and complete delineation of neointima was obtained in all 24
cases.
Conclusion: Contrast IVUS imaging improves detection of in-stent neoin-
tima and provides detailed information for quantitative analysis of in-stent
neointima.
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1105O-155IRelationBeWeenPerfusion,MetabOh*m,end
Contractile Reaerve in Repetitive Myocardial
Stunning
M. Di Carti, P.Prcevaki, M. Leonen, T. Singh, O. Muzik, R. Vander Heide.
WayneState Urrivareify Datroit, Ml, USA
The purpose of this study was to determine the contractile reserve and
its relation to regional perfusion and metabolism in an acute canine model
of repetitive myooerdial stunning. Ten dogs underwent four 5 min balloon
occlusions of the LAD coronaw artery, each separated by 5 min of reper-
fusion. Regional myocardial blood flow (MBF), metabolism, and systolic
function (SF) were evaluated at baseline (n = 5) and during dobutamine
stimulation (7.5 @k@min, n = 5) two hours after reperfusion, Regional
SF (expressed as % wall thickening) was assessed with 2-D echo. MBF,
oxidative metabolism (MV02), and glucose uptake (during hyperinsulinemic-
euglycemic clamp) were quantified using [N-13]-ammonia, [C-11]-acetate,
and [F-18]-deoxyglucose and dynamic PET imaging. After the 4 cycles of is-
chemia, SF in reperfused myocardium was severely decreased (45 + 21% of
remote, normal myocardium) despite near-normal MBF (0.91 + 0.2 ml/g/min,
95 + 7% of remote), Despite depressed SF, glucose uptake (79 + 11% of
remote) and MV02 (83+7% of remote) were only modestly decreased. With
dobutamine, MBF (from 0.91 + 0.2 to 1.6 + 0.2 ml/g/min, P < 0.01), glucose
uptake (from 0.3 A 0.1 to 0.56 + 0.3 wmol/g/min, P < 0.05) and MV02 (k,
from 0.09 + 0.02 to0.17 + 0.02 rein-l, P < 0.05) increased significantly by z
75% of baseline. SF also improved, although only modestly (from 45 + 21%
to72 + 18%of remote, P <0.01). Asa result, estimates of regional efficiency
(SF/MV02) in stunned myocardium were decreased at rest (3+ 0.4 vs 7 + 2
in remote, P < 0.05) and remained impaired during dobutamine stimulation
(3.9 + 1 vs 8.8 + 1 in remote, P < 0.05). Thus, inotropic stimulation of
repetitive stunned myocardium induced a proportional augmentation of MBF,
MV02, and glucose uptake, which was uncoupled from cardiac work. The
preserved myocardial perfusion and metabolic reserve supports the notion
that myocerdial stunning is attributable to a primary defect in the contractile
machinety.
1050-156 Prognosis in Patienta With Left Bundle Branch
Block and Normal Ditwridamole Thallium-201
Scintigraphy .-
M. Almeida, A. Ventosa, V. Gil, C. Aguiar, J. Ferreira, J. Calqueiro,
Ft.Seabra-Gomes. Hospitalde Santa Cruz/krstituto do Cora@o, Carrraxide,
Portugal
Background; The presence of complete left bundle branch block (LBBB)
is commonly associated with a poorer prognosis, specially in patients (pts)
with coronary disease (CAD), Outside this context a normal dipyridamole
thallium-201 scintigraphy is a strong marker of a favorable outcome.
Objective: To assess the prognosis in patients with LBBB and a normal
dipyridamole thallium-201 scintigram.
Population and Methods: Patients with complete LBBB and normal my-
ocardial perfusion which performed dipyridamole SPECTthallium-201 scintig-
raphy inourcenterfor suspectedCAD between 1988and 1995,were followed
for clinical events during at Ieaat 12 montha.
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Resu/te:69pts (36female) with59 + IOyearswerefollowed durfng 29.2 +
20.5 months. There were no major cardiovascular events (death, myooardial
infarction). Four pts had clinical unstable angina. All events occurred at least
2 years after the thallium-201 scintigraphy.
Conclusion: The presence of a normal myocardial perfusion with dipyri-
damole thallium-201 scintigraphy, in this group of pte with suspected CAD
and LBBB, was associated with a very good prognosis, with a low rate of
minor events, occurring only after 2 years, and without major cardiovascular
events.
I105O-157IHigh Dose DipyrldamoleStrea~ imaging:
Comparison of Sestsmibi Scintigraphy and
2D-Echocardiography for the Detection of
Coronary Artery Disease. A Multicenter Study
G. Parodi, C. Marcassa, E. Piceno, P. Marzullo, E. Verna, G. Bisi, M. GalIi,
S. Pirelli, G. Sambuceti, O. Parodi for the Italian Group of Nuclear
Cardiology. CNR Institute of Clinical Physiobg~ Pisa, Italy
In order to compare the relative accuracy of high dose (up to 0.84 mg/kg over
10’) dipyrldamole stress imaging with two-dimensional echocardiography
(ECHO) and sestemibi scintigraphy (MIBI) for detection of coronary artery
disease (CAD), 101 patients with chest pain history and no previous myocer-
dial infarction, were studied simultaneously with MIBI and ECHO during a
high dose dipyridamole stress in 7 different Institutions. At coronary angiog-
raphy, 21 patients had non-significant, and 80 significant (~ 5W0 diameter
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reduction) CAD: 37 had single, 19 double and 24 triple vessel disease. Sen-
sitivity for detection of CAD was 78% for ECHO and 84% for MIBI (p = ns).
Specificity was 77% for ECHO and 91% for MIBI (p= ns). Overall accuracy
was 78Y0for ECHO and 85% for MIBI (p = ns). Intercanter variation in ac-
curacy ranged from 50% to 100% for ECHO (variation coefficient = 19.7)
and from 79% to 100% for MIBI (variation coefficient= 8.2). Angiographically
assessed extent and severity of CAD evaluated by the Duke score waa cor-
related to the extent and severity of both parfusion defects (each segment
scored from O= normal to 3 = absent tracer uptake) with MIBI (r= 0.55, p <
0.01) and functional impairment (each segment scored from O= normal to 3
= dyskinetic) by ECHO (r = 0.50, p < 0.01). In conclusion, MIBI and ECHO
have comparable accuracy for noninvasive identification of angiogrephicelly
assessed CAD during high dose dipytfdamole stress. InterCentervariability
in diagnostic accuracy is higher for ECHO than MIBI. Both methods allow
a reasonably accurate estimation of extent and aaverity of CAD through a
samiquantitetiva assessment of extent and severity of perfusion or functional
defects.
1050-158 ComparisonBetweenTI-201andTc-99m-NOET
MyocardialUptakeDuringAdenoaineHyparemia
in DogswithMildto ModerateCoronary
Stanoees
D.K. Glover, M. Ruiz, G. Vanzetto, D.A. Calnon, D.D. Watson, G.A. Beller.
Univereityof Virginia, Charfottesvi//e, VA, USA
We have previously demonstrated thatthe myocerdial uptake of TI-201 (TI)
more accurately tracks coronary flow during adenoaine (Ado) hyperemia
than either Tc-99m-sestamibi ortetrofosmin. NOET is a new Tc-99m-labeled
myocardial perfusion tracer which redistributes similar to T1.We compared
TI and NOET uptake in 9 dogs with either critical (n = 4) or mild (n = 5)
IAD stenoses after simultaneous injection with microsphere during Ado
infuaion (300 w@kg/min). As shown, 5 min after injection, NOET uptake by
gamma well counting was higher than TI overa wide range of flow. Although
both TI and NOET uptake underestimated the magnitude of flow disparity,
NOET more closely matched flow. The mean flow and tracer activity ratios
(LAD/LCX) were:
Group Flow -t-l NOET
Critical 0.14* 0.02 0.51i 0.05* 0.34i o.03*t *p< 0,01W Flow
Mild 0.53* 0.09 0.78h 0.07* 0,71* o.07*t tp <0,05 vsm
I
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Thus, NOET appears to be the firat Tc-99m-labslsd myocardial perfusion
tracer with myocadial retention higher than TI after 5 min. This finding,
combined with its redistribution property, suggest that NOET may be well
suited for pharmacologic stress imaging.
~050~159/ M~ocardialBloodFIOwVaTraCerUptake
Characteristicof PerfusionTracersDuring
DobutsmineStress
A.Roaenbaum, A.J. McGoron, M.C. Gereon, R.W. Millard, M. Gabel,
D. Biniakiewicz, R.A. Walsh. Univcwsityof Cincinnati, Cihcirrnati, OH, USA
The relationship between tracer uptake and myocardial blocd flow (MBF) for
multiple Tc-99m.labalad perfusion tracers has not been previously rapotied
uaing dobutemine, which is used to simulate axercise. Therefore, in an open
cheat canine modetofischemia (18 dogs), durfngdobutamine infusion, the ra-
Iationship between myocardial tracer uptake and MBF was characterized for
six tracers (TI-201, Tc99m-Q3, Tc99m-Q12, Tc99m-Q4, Tc99m-tetrofosmin
(Tetro),Tc99m-sestemibi (MIBI)).
Dobutamine effect was varifiad by a statistically significant increase in
dP/df and coronary flow, with no difference among tracer groups. The data
were combined after normalizing to the average tracer activity and MBF
for each dog. The relation between tracer uptake (% average) vs. MBF (%
average) wss analyzed by linear regression. The number of samples (n),
correlation coefficient (r), line alopa, and y intercept are presented in the
following tabla:
TL-201 Q3 Q4 Q12 Tetro MIBI
n 266 201 268 266 268 201
0.94 0.97 0.91 0.95 0.90 0.92
:Iope 0,64” 0.77’ 0.62”” 0.61*” 0.72;” 0.60*-
Intercept 0.16” 0.23” 0.39”” 0.39*” 0.32*- o.40*-
*p< 0,01 comparedto Q3; “p <0.01 compared to T1-201 by ANOVA,
In conclusion, the flow vs. uptake characteristics of Tc99m-Q3 and T1-201
during dobutamine infusion are superior to the remaining tracers.
1105O-16OIDSte.tiOnofMildandsaverSCoronaryArtery
StenoeesbyDipyridsmols‘l Thalliumva
Dipyridamole‘gmTc-Tetrofosmin
P. Raggi, G.A. Beller, H. Shanoudy, G.M. Tussey, A. Soliman, D.D. Watson.
VeteransAffairs Medics/ Centec Sa/em, VA, USA, University of Virginia,
Cfrar/ottesvi//e,Virginia, USA
Animal experiments have shown ‘gmTc-Tetrofosmin(Tetro)to reach a plateau
of myocerdialextraction with increasing corona~ blood flow rates atan aarlier
stage than .201Thallium (Th). Tharefore, the detection of mild coronawartery
stenoaes might be superior with Dipyrfdamole (DP) Th than DP-Tatro. We
conducted a randomized trial in 21 consecutive patients with angiographicelly
demonstrated corona~ artety disease using SPECT DP-Th vs SPECT DP-
Tetro. Quantitative coronary angiography was employed to aasess severity
of vessel stanoaes. A total number of 19 mild coronary artery stenosea (50-
70%), 19 severa stenoses (71-99%) and 10 total occlusions waa identified.
SPECT DP-Th revealed a perfusion defect in 13 (88%) of 19 territories
patfused by vessels with mild stenoses (10 were reversible). SPECT DP-
Tetro identified 7 (37%) defects in the sama 19 territories (3 wera reversible;
one sided T-teat for reversible defects, p = 0.05; two-sided p = 0.1). DP-Th
and DP-Tetro identified an equal number of defects in areas perfused by
coronary arteries with severe stenoaes or total occlusions (76% and 72%).
Conclusion: Though only with a marginal statistical difference, SPECT DP-
Th detects more reversible perfusion defects in mild corona~ artery diseaae
than DP-Tetro.Thedetaction rate for defects interritorias perfused byveaeels
with severe stenosas is similar.
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I 1051-135/ EfficscysndSsfetyoflntrsvenoueJy
AdministeredDofetilidein theAcuteTermination
ofAtrialFibrillationsndFlutter.A Multicenter,
Randomized,Double-blind,and
Placebo-controlledTrial
B.L. Norgaard 1, K. Wachtell, P.D.Christensen, A. Thomassen,
J.B. Johensen, E.H. Christianson, O. Graff 2.1 Aarfrus Amtsaygehus Univ.
Hospital, Aarfrus, Denmark, 2Pfizer Central Research, Sandwich, England
The purpose waatoassassthe clinical efficacy and safety of intravenous (iv.)
dofetilide, a new selactive potassium channel blocker, in acute termination
of atrial fibrillation (AF) and fluttar (AFI). Ninety-eight patients with AF/AFl
of a duration from ona hour to six months prior to screening were randomly
allocated to receiva a doaa of dofetilide 8 p~kg or placebo infused iv. over
a period of 30 minutea. Respondera were defined as patiants convening to
sinus rhythm within three hours after the start of infusion.
Resu/ts:Sixty-seven patients received dofetilide and 31 received placebo.
The two groups had comparable baseline characteristics. Nineteen (28.4%)
patients receiving dofetilide and one (3.2%) patient receiving placebo re-
sponded to treatment (p = 0.005). Pre-study mean duration of AF/AFl was
68 + 80 days for responders varsus 75 + 51 days for non-respondera (p ‘
= 0.54). Two patiants (3%) developad toreade de pointes ventricular tachy-
cerdia (TdPVT) in relation to dofetilide infusion. Prior to the occurrence of
TdPVT, infusion of dofetilide was prematurely tanminateddue to gross distor-
tion of T-wave morphology. Both TdPVT-patients were successfully treated
with magnesium chloride iv.. The occurrence of proarrhythmia wee not asso-
ciated to dofetilide plasma concentration. No other cardiac or extra-cardiac
side effects were noted.
Conclusions: Intravenous dofetilide 8 @kg over~ minutes is effective in
acute termination of AF/AFl. The incidence of proarrhythmia ia comparable
to what has been observed with other antiarrhythmic agents.
